The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices,
December 05, 2022
Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) Shortage - Letter to Health Care Providers
December 5, 2022 —  The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a…
Read More
December 05, 2022
Top 10 Most-read Content in November
Here is a recap of what DAIC viewers found most interesting during the month of November: 1. Study Finds That Risk of…
Read More
Ms. Nieves, donor family, and doctors. Photo courtesy of Montefiore Health System.
December 02, 2022
World's First HIV-Positive to HIV-Positive Heart Transplant Recipient Meets Donor Family, Shares Gratitude for Life & Advocates for Organ Donation
December 2, 2022 —  Westchester resident, 62-year-old Miriam Nieves, is especially grateful this Thanksgiving season.…
Read More
Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System.
December 02, 2022
Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2 Aortic Valve System
December 2, 2022 —  Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market…
Read More
Last year, U.S. Congressman Andy Barr (KY-06) introduced this legislation in the House to honor the legacy of his wife, Carol Leavell Barr, who passed away tragically from sudden cardiac death brought on by mitral valve prolapse, an underlying heart condition that causes death in .2% of cases.
December 02, 2022
CAROL Act Will Prioritize Research on Heart Valve Disease
December 2, 2022 —  The U.S. Senate today passed the bipartisan Cardiovascular Advances in Research and Opportunities…
Read More
Transverse heart sections from wild type mice (WT) and transgenic mice overexpressing beta-3 adrenergic receptor in cardiomyocytes (c-hB3tg) after 3 months of aortic stenosis (transaortic constriction, TAC) or control (sham). Hypertrophy after TAC was less severe in the transgenic mice. Courtesy of CNIC
December 01, 2022
A New Therapeutic Target for the Prevention of Heart Failure Due to Aortic Stenosis
December 1, 2022 —  Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a new…
Read More
Annalise.ai and Nuance announced that the global medical imaging AI company has joined the Nuance Precision Imaging Network (PIN), connecting Annalise.ai workflow orchestration and diagnostic support solutions to over 12,000 healthcare facilities worldwide.
December 01, 2022
HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms
December 1, 2022 —  Heart Test Laboratories, Inc. d/b/a HeartSciences, a medical technology company focused on saving…
Read More
A team led by UTHealth Houston's K. Lance Gould, MD, (center) used PET imaging technology (shown above) to map coronary blood flow and its outcomes among heart disease patients. (Photo by UTHealth Houston)
December 01, 2022
PET Technology More Effective Than Angiogram at Determining Need for Coronary Stents, Bypass Surgery
December 1, 2022 —  A new method for determining whether patients with heart disease need coronary stents or bypass…
Read More
November 30, 2022
Cardiothoracic Surgeon to Lead Smidt Heart Institute's ECMO Program
November 30, 2022 — The Smidt Heart Institute at Cedars-Sinai has selected board-certified cardiothoracic surgeon Tyler…
Read More
Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System.
November 30, 2022
Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2 Aortic Valve System
November 30, 2022 — Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market…
Read More
Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System.
November 30, 2022
Medtronic’s Next-Gen Evolut FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting
November 30, 2022 — Medtronic’s newest generation self-expanding, transcatheter aortic valve replacement (TAVR) system…
Read More
Figure 1. Normal chest X-ray
November 29, 2022
AI Predicts Heart Disease Risk Using Single X-Ray
November 29, 2022 — Researchers have developed a deep learning model that uses a single chest X-ray to predict the 10-…
Read More
Tanya Therapeutics announced today that the US FDA has granted orphan drug designation for its second gene therapy product candidate, TN-401, for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC)
November 28, 2022
Tenaya Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy
November 28, 2022 – Tenaya Therapeutics, a clinical-stage biotechnology company with a mission to discover, develop and…
Read More
BIOTRONIK announced their presentation of the one-year results from the investigator-initiated BIOPACT RCT this week
November 28, 2022
One-Year BIOPACT Randomized Controlled Trial (RCT) Results Demonstrate Excellent Results for Low-Profile Passeo-18 Lux DCB
November 28, 2022 – BIOTRONIK announced the presentation of one-year results from the investigator-initiatedBIOPACT…
Read More
Today, UltraSight announced the findings from a landmark pivotal study that confirms its AI guidance technology enables novice ultrasound users to acquire high-quality diagnostic images of the 10 standard cardiac views.
November 28, 2022
New Landmark Study Indicates UltraSight Enables Novice Ultrasound Users to Capture High Quality Cardiac Images
November 28, 2022 – UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power…
Read More
Published online November 8 in the journal, Radiology, the study enabled the visualization of pulmonary hemodynamics and perfusion with high sensitivity, specificity and diagnostic accuracy, and without the use of contrast media
November 28, 2022
Study Reports Similar Efficacy of Dynamic Digital Radiography of the Chest with Lung Ventilation Perfusion for Detection of Chronic Thromboembolic Pulmonary Hypertension
November 28, 2022 — Konica Minolta Healthcare Americas, Inc., a leader in medical diagnostic imaging and healthcare…
Read More
Survivors face higher risk of cardiac events that can reduce their life expectancy by decades
November 25, 2022
Study Finds That Risk of Myocarditis After SARS-CoV-2 Vaccination is Increased But Very Low
November 25, 2022 —  A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger…
Read More
Left: Echocardiogram at birth shows severe non-delamination of the tricuspid valve septal leaflet, with coaptation point near the right ventricle apex (marked with arrow). The right ventricle is small, while the right atrium is large. Right: Jaxon’s echocardiogram today shows a normal tricuspid valve position (marked with arrow) and normal sizes of the right atrium and right ventricle.
November 25, 2022
From Severe Ebstein Anomaly to a Normal Heart
November 25, 2022 —  Jodie Votava-Smith, MD, has pulled up two side-by-side echocardiograms on her computer screen and…
Read More
The Cardiovascular Research Foundation has announced its Inaugural Pulse‑Setter Awards, including Pulse-setter Champion and Women as One Co-Founder, Roxana Mehran, MD.
November 23, 2022
Women as One Co-Founder Among Four to Receive Inaugural CRF Awards
November 23, 2022 — The Cardiovascular Research Foundation (CRF) has announced its inaugural Pulse‑Setter Awards,…
Read More
Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value
November 23, 2022
Viz.ai Announces Positive New Data From Large Aortic Dissection AI Real-World Study at the 2022 VEITHsymposium
November 23, 2022 — Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now